Psilocybin vs SSRI: Long-Term Well-Being Compared

Psilocybin vs SSRI for depression: Psilocybin vs SSRI: Long-Term Well-Being Compared

In a six-month follow-up of a small phase 2 randomized controlled trial, adults with moderate to severe depression who received psilocybin therapy showed greater improvements in work and social functioning, meaning in life, and connectedness than those who received the SSRI escitalopram, though both groups reduced depressive symptom scores at similar levels. Key takeaways Comparable […]

What Six Trials Now Tell Us About Psilocybin for Depression

Psilocybin for depression: What Six Trials Now Tell Us About Psilocybin for Depression - The Church of Psychedelics

A systematic review and meta-analysis published in the Journal of Affective Disorders by researchers at Fujita Health University and Keio University School of Medicine has pooled data from six randomized controlled trials to assess how psilocybin therapy performs against control conditions in treating major depressive disorder (MDD), tracking both efficacy and safety across multiple time […]

A Standardized Psilocybin Protocol for Depression Passes Its First Real Test

Psychedelic therapy for depression: A Standardized Psilocybin Protocol for Depression Passes Its First Real Test - The Church of Psychedelics

A new pilot trial of psychedelic therapy for major depressive disorder has produced results that researchers describe as showing significant promise, and, perhaps more importantly for the field, the trial was built around a standardized protocol designed to be replicated across clinical settings. If the approach holds up in larger studies, it could mark a […]